Epstein-Barr virus in normal pregnant women. 1982

K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo

Acquired immune suppression accompanying normal pregnancy may be associated with reactivation of Epstein-Barr virus (EBV). Pregnant women with reactivated EBV having anti-EA antibodies show high titers of antiviral capsid antigen (VCA) geometric mean titers (GMT) of 522 versus 170 in those lacking anti-early antigen (EA). Among twenty-seven seropositive women at parturition, 17 (63%) had generated antibody to EA, and all 27 (100%) demonstrated significant increases in antibody to VCA (p less than 0.01). In contrast, antibody titers to cytomegalovirus, herpes hominis, varicella-zoster, and rubella viruses in the pregnant women were comparable to those found in nonpregnant controls. (Am J Reprod Immunol. 1982; 2:217-221.)

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody
D012412 Rubella virus The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. Measles Virus, German,German Measles Virus

Related Publications

K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
April 1982, The Journal of infectious diseases,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
November 1982, Ceskoslovenska pediatrie,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
June 1985, European journal of clinical microbiology,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
January 2013, PloS one,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
March 2005, Pediatrics in review,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
January 2002, Virus research,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
September 2011, Pediatrics in review,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
March 2003, Nihon rinsho. Japanese journal of clinical medicine,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
January 1980, La Revue du praticien,
K Sakamoto, and J Greally, and R F Gilfillan, and J Sexton, and V Barnabei, and J Yetz, and T Bechtold, and J K Seeley, and E O'Dwyer, and D T Purtilo
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!